Hospital
Desoto County Hospital District
Desoto County Hospital District was paid $10.76M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 15% of everything it billed.
33Billing provider infoDESOTO COUNTY HOSPITAL DISTRICT
ARCADIA, FL 34266
ARCADIA, FL 34266
33aNPI1528387842assigned 05/26/2010
33bProvider typeRural Acute Care Hospital
28Total paid$10.76M
24GClaims252,808
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,007 | $254K | |
| 2019 | 41,952 | $1.63M | |
| 2020 | 40,284 | $1.29M | |
| 2021 | 57,321 | $2.23M | |
| 2022 | 55,255 | $2.61M | |
| 2023 | 32,677 | $1.75M | |
| 2024incomplete | 15,312 | $993K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 15% | 8,668 | 2,418 | $1.58M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 12,084 | 11,053 | $1.55M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.5% | 7,265 | 6,607 | $915K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 8,298 | 7,783 | $881K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 8.1% | 12,988 | 3,566 | $870K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.3% | 6,813 | 1,983 | $673K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 1,504 | 1,356 | $448K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.5% | 1,992 | 1,697 | $381K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3.5% | 2,992 | 1,059 | $374K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.4% | 3,830 | 3,633 | $364K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.8% | 3,710 | 3,035 | $297K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.7% | 5,253 | 252 | $290K |
125 more codes
| 80053 | Comprehensive metabolic panel | 1.6% | 15,546 | $170K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 5,720 | $151K |
| 99285 | Emergency room visit (most serious) | 1.4% | 2,011 | $148K |
| 87430 | 1.1% | 7,281 | $120K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.0% | 1,059 | $112K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,014 | $97K |
| 87428 | <1% | 2,840 | $93K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,965 | $85K |
| 81003 | <1% | 9,379 | $77K | |
| 96116 | <1% | 104 | $64K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,739 | $63K |
| G0378 | Hospital observation service, per hour | <1% | 1,126 | $63K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,672 | $57K |
| 92523 | <1% | 244 | $48K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 283 | $39K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 7,994 | $37K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 96 | $35K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,300 | $34K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,324 | $29K |
| 96112 | <1% | 65 | $28K | |
| 97162 | <1% | 180 | $25K | |
| 80305 | <1% | 2,862 | $25K | |
| 84703 | <1% | 4,782 | $24K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,364 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,678 | $23K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 967 | $22K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 405 | $20K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 335 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,197 | $19K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 464 | $19K |
| 84484 | <1% | 3,757 | $18K | |
| 73630 | <1% | 510 | $18K | |
| 97167 | <1% | 82 | $15K | |
| 73562 | <1% | 336 | $15K | |
| 83690 | <1% | 3,861 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,599 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,262 | $13K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,096 | $13K |
| 87806 | <1% | 672 | $11K | |
| 73610 | <1% | 227 | $10K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 191 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,303 | $10K |
| 87420 | <1% | 188 | $10K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 69 | $9K |
| 87081 | <1% | 90 | $9K | |
| 97163 | <1% | 30 | $9K | |
| 83605 | <1% | 1,555 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 10,455 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 249 | $7K |
| 86328 | <1% | 487 | $7K | |
| 87040 | <1% | 1,630 | $7K | |
| 73130 | <1% | 178 | $7K | |
| 97116 | <1% | 162 | $6K | |
| 85610 | <1% | 1,435 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 767 | $6K |
| 84702 | <1% | 1,092 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 216 | $6K |
| 87486 | <1% | 1,039 | $5K | |
| 82150 | <1% | 1,504 | $5K | |
| 84439 | <1% | 1,053 | $5K | |
| 80061 | Lipid panel | <1% | 2,852 | $5K |
| 97161 | <1% | 45 | $5K | |
| 97166 | <1% | 24 | $4K | |
| 83874 | <1% | 1,093 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,373 | $4K |
| 96376 | <1% | 759 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 83 | $4K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 147 | $3K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,100 | $3K |
| 87077 | <1% | 1,221 | $3K | |
| 83880 | <1% | 805 | $3K | |
| 74019 | <1% | 14 | $3K | |
| 87186 | <1% | 1,269 | $2K | |
| 0011A | <1% | 202 | $2K | |
| 83735 | <1% | 1,221 | $2K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 645 | $2K |
| 0012A | <1% | 184 | $2K | |
| 73110 | <1% | 61 | $2K | |
| 82803 | <1% | 208 | $2K | |
| 86850 | <1% | 279 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $2K |
| 86900 | <1% | 535 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $1K |
| 87070 | <1% | 136 | $1K | |
| 86901 | <1% | 535 | $1K | |
| 85730 | <1% | 620 | $1K | |
| 73030 | <1% | 44 | $1K | |
| 74022 | <1% | 29 | $1K | |
| 82728 | <1% | 261 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 41 | $1K |
| 12001 | <1% | 12 | $874.46 | |
| 85379 | <1% | 283 | $853.80 | |
| 74018 | <1% | 70 | $696.08 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 32 | $584.67 |
| 86592 | <1% | 573 | $576.04 | |
| 86140 | <1% | 318 | $526.65 | |
| 86769 | <1% | 480 | $503.85 | |
| 82607 | <1% | 361 | $465.73 | |
| 85652 | <1% | 379 | $461.77 | |
| 85027 | <1% | 804 | $444.42 | |
| 82043 | <1% | 140 | $436.09 | |
| 87340 | <1% | 380 | $368.94 | |
| 81001 | <1% | 76 | $313.01 | |
| 83550 | <1% | 143 | $286.28 | |
| 82947 | <1% | 43 | $161.34 | |
| 87581 | <1% | 1,040 | $138.66 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,041 | $138.66 |
| G9019 | Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) | <1% | 21 | $131.47 |
| 82746 | <1% | 112 | $100.84 | |
| 82570 | <1% | 265 | $89.10 | |
| 84436 | <1% | 210 | $62.12 | |
| 86803 | <1% | 160 | $50.00 | |
| 84479 | <1% | 146 | $25.07 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 28 | $14.50 |
| 84550 | <1% | 26 | $7.80 | |
| 82950 | <1% | 12 | $4.86 | |
| 82550 | 0% | 15 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 15 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 17 | $0.00 |
| 86762 | 0% | 16 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 186 | $0.00 |
| 84145 | 0% | 13 | $0.00 | |
| 96113 | 0% | 65 | $0.00 | |
| 87075 | 0% | 14 | $0.00 | |
| 83525 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSICA, VINCENT (CEO)
| Provider | Location | Paid |
|---|---|---|
| DCHD Health Care Professionals LLC | Arcadia, FL | $64K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.